此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Perioperative Prospective Follow Up Of Cannabis Consumers and Discrepancy Use

2026年5月7日 更新者:Elyad Davidson、Hadassah Medical Organization

Perioperative Prospective Follow Up Of Cannabis Consumers

This study includes a prospective non interventional study that aims to asses the prevalence of cannabis use among patients undergoing elective surgery and evaluates its impact on perioperative outcomes, including pain, opioid consumption, nausea, anxiety, and sleep disturbances. A matched control cohort will provide comparative data. Discrepancies between self-reported and objectively measured cannabis use will be assessed using blood samples and urine samples. Participants will be requested to complete preoperative and postoperative questionnaires on days 1, 2, 3, 7, and 30 to monitor cannabis use and perioperative symptoms. This study aims to clarify the perioperative effects of cannabis use and the accuracy of patient-reported consumption.

研究概览

详细说明

This study aims to assess the proportion of cannabis users who undergo surgery. In addition, we seek to evaluate whether chronic cannabis use affects the perioperative period. Specifically, we will examine whether cannabis use around the time of surgery influences levels of pain, opioid consumption, nausea, anxiety, and sleep disturbances.

A matched control cohort with similar patient characteristics will be used for comparison.

Another key objective is to assess discrepancies between patients' self-reported cannabis use and their actual usage. This will be evaluated by comparing patient-reported data to objective measures such as blood test results and documented cannabis levels in medical records. We hypothesize that patients tend to underreport their cannabis use relative to the levels detected through clinical testing.

Following signing an informed consent, study participants will be asked to complete a preoperative questionnaire to assess their cannabis consumption habits.

Prior to anesthesia adminsatration, a 6 cc blood sample will be collected from the patient's intravenous line. This sample will be used to measure cannabis levels in the blood, allowing for a comparison between self-reported cannabis use and actual detected levels. The sample will be immediately labeled with a unique serial number in the operating room. After plasma separation via centrifugation, the sample will be frozen for later analysis using high-performance liquid chromatography (HPLC . All samples will be deidentified to external personal.

Following surgery, participants will be asked to complete questions postoperatively up to 7 days. These follow-ups will gather information on any changes in cannabis use as well as symptoms such as pain intensity, nausea, sleep quality, and use of rescue medications.

研究类型

观察性的

注册 (估计的)

600

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Jerusalem、以色列、9210141
        • Hadassah Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

取样方法

非概率样本

研究人群

The study population will consist of patients scheduled to undergo elective surgery.

This will include individuals who regularly use cannabis, as well as a matched control cohort with similar demographics who do not use cannabis.

描述

Inclusion Criteria:

  • Patients who use cannabis and are scheduled to undergo elective surgery.
  • A matched control cohort of patients with similar demographics who are also scheduled for elective surgery.

Exclusion Criteria:

None

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Study cohort: patients undergoing elective surgery who use cannabis.
Control cohort: patients undergoing elective surgery who do not regularly use cannabis.
urine sample
control group
Patients undergoing elective surgery who do not use cannabis regularly
urine sample

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
discrepancy percentage between reported cannabis users and actual cannabis usage among patients undergoing elective surgery.
大体时间:up to 7 days
up to 7 days
Use of Cannabis
大体时间:up to 7 days postopertively
Doasge Use of Cannabis
up to 7 days postopertively

次要结果测量

结果测量
措施说明
大体时间
Pain levels during surgery as assesed using VAS
大体时间:up to 7 days
We aim to assess whether pain levels during surgery are affected by cannabis use of the VAS questionaire
up to 7 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Elyad Davidson, MD、Hadassah medical center/ Hebrew univeristy

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年5月6日

初级完成 (估计的)

2026年7月10日

研究完成 (估计的)

2027年12月10日

研究注册日期

首次提交

2025年9月7日

首先提交符合 QC 标准的

2026年5月7日

首次发布 (实际的)

2026年5月12日

研究记录更新

最后更新发布 (实际的)

2026年5月12日

上次提交的符合 QC 标准的更新

2026年5月7日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅